RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023
framework aligns physician behavior with payment incentives under RGB-FPS and mitigates excessive competition.Further research is needed to refine discounting mechanisms for excess volumes.
Authors
- Ken Inada (ORCID: https://orcid.org/0000-0002-3073-4588)
- Manabu Akazawa (ORCID: https://orcid.org/0000-0002-4112-6035)
- Ryosuke Kumazawa (ORCID: https://orcid.org/0000-0002-8694-6803)
- Ryutaro Suzuki
Institutions
- Meiji Pharmaceutical University (JP)
- Kitasato University (JP)
Publication Details
- Journal
- Value in Health Regional Issues
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.vhri.2025.101349
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 0.00